Investigative reporter Martha Rosenberg breaks down why a drug maker sponsored trial with a surrogate endpoint gets covered as dementia news.

🎧 Search "The Podcast by KevinMD" on Apple or Spotify

Before you trust the next dementia drug headline, check what the trial measured and who paid for it.

#Shorts #Dementia #PharmaMarketing